Are you Dr. Tehlirian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5701 Eaglebend Dr
Richardson, TX 75082Phone+1 972-437-4339
Summary
- Dr. Christopher Tehlirian, MD is a rheumatologist in Richardson, Texas. He is currently licensed to practice medicine in Texas and Massachusetts.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2005 - 2007- Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
McGovern Medical School at UTHealthClass of 2002
Certifications & Licensure
MA State Medical License 2013 - 2021
TX State Medical License 2007 - 2014
Publications & Presentations
PubMed
- 22 citationsSafety and Pharmacokinetics of the Oral TYK2 Inhibitor PF-06826647: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation StudyRavi Shankar P. Singh, Vivek Pradhan, Erika S. Roberts, Matthew Scaramozza, Elizabeth Kieras
Clinical and Translational Science. 2021-03-01 - 13 citationsSafety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomi...Christopher Tehlirian, Elena Peeva, Elizabeth Kieras, Matthew Scaramozza, Erika S Roberts
The Lancet. Rheumatology. 2021-03-01 - 64 citationsTYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial.Seth B Forman, David M. Pariser, Yves Poulin, Michael S. Vincent, Steven A. Gilbert
The Journal of Investigative Dermatology. 2020-12-01
Other Languages
- Spanish, Chinese (Mandarin)
